Skip to main content

Advertisement

Open Peer Review Reports for: Monospecific antibody targeting of CDH11 inhibits epithelial-to-mesenchymal transition and represses cancer stem cell-like phenotype by up-regulating miR-335 in metastatic breast cancer, in vitro and in vivo

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
13 Mar 2019 Submitted Original manuscript
30 Mar 2019 Reviewed Reviewer Report - Yang Zhao
18 Apr 2019 Reviewed Reviewer Report - Julie Decock
20 Apr 2019 Reviewed Reviewer Report - Nik Soriani Yaacob
7 May 2019 Author responded Author comments - Jia-Hong Chen
Resubmission - Version 2
7 May 2019 Submitted Manuscript version 2
9 May 2019 Reviewed Reviewer Report - Julie Decock
27 May 2019 Reviewed Reviewer Report - Nik Soriani Yaacob
30 May 2019 Author responded Author comments - Jia-Hong Chen
Resubmission - Version 3
30 May 2019 Submitted Manuscript version 3
5 Jun 2019 Author responded Author comments - Jia-Hong Chen
Resubmission - Version 4
5 Jun 2019 Submitted Manuscript version 4
Publishing
9 Jun 2019 Editorially accepted
27 Jun 2019 Article published 10.1186/s12885-019-5811-1

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement